U.S. Federal Trade Commission: FTC staff finds Sanofi-Aventis, Watson Pharmaceuticals, and Synthon Holding failed to report drug patent agreements as required by law
MLex Summary: The Federal Trade Commission said Tuesday that it has notified Sanofi-Aventis, Watson Pharmaceuticals and Synthon Holding that the companies violated federal law by failing to inform antitrust authorities about drug patent...To view the full article, register now.
Already a subscriber? Click here to view full article